ArticleMicrobiologyOpen2026
Prevalence, Molecular Identification, and Antimicrobial Resistance Traits of Pasteurella multocida Isolated From Nasal Swabs of Buffaloes in Bangladesh.
Article in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Pasteurella multocida is an important bacterial respiratory pathogen of buffaloes and may cause major economic losses in the livestock sector. But there is a lack of data on its prevalence, risk factors, and antimicrobial resistance patterns in Bangladesh. The study was cross-sectional, and a total of 400 buffaloes from seven locations in Bangladesh were included in the nasal swab collection. Isolation was done using culture methods and confirmed by polymerase chain reaction (PCR). Associations between infection and risk factors were explored using logistic regression analysis; antibiotic susceptibility was determined by the disc diffusion method. The co-resistance patterns were assessed by Pearson's correlation analysis. The culture-based prevalence of P. multocida was 12.25%, compared with a PCR-confirmed prevalence of 7.25%; all PCR-positive isolates were capsular type B, with notable regional variation in prevalence. Buffaloes with respiratory symptoms had significantly greater odds of being infected (OR = 8.88, p < 0.001), and the younger group of animals aged 1-3 years had a greater predisposition to infection than the younger ones, but sex was not significantly associated with infection. The isolates exhibited high antibiotic resistance, as demonstrated by antimicrobial susceptibility testing, particularly against ampicillin (96.55%), oxytetracycline (93.10%), and penicillin-G (89.65%). Cefixime (93.10%) and azithromycin (68.96%) remained largely effective by contrast. Positive correlations were identified between resistance to β-lactams, tetracyclines, and aminoglycosides. These findings suggest that multidrug-resistant P. multocida type B is circulating in buffaloes in Bangladesh and highlight the need for increased surveillance, rational use of antimicrobials, and integrated control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.